Lipid peroxidation may predict restenosis after coronary balloon angioplasty

被引:14
作者
Imai, K
Matsubara, T
Kanashiro, M
Ichimiya, S
Hotta, N
机构
[1] Nagoya Univ, Sch Med, Dept Internal Med 3, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Yokkaichi Municipal Hosp, Dept Cardiol, Yokkaichi, Japan
来源
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 2001年 / 65卷 / 06期
关键词
coronary balloon angioplasty; lipid peroxidation; restenosis; thiobarbituric acid reactive substances;
D O I
10.1253/jcj.65.495
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 [哲学]; 0101 [哲学]; 010108 [科学技术哲学]; 060207 [中国近代史]; 060305 [世界专门史]; 0712 [科学技术史];
摘要
The present study assessed whether lipid peroxidation in plasma might predict restenosis after coronary balloon angioplasty. A total of 87 patients, who had undergone successful coronary balloon angioplasty using standard techniques, were enrolled. Fasting blood samples before the intervention were measured for plasma levels of thiobarbituric acid reactive substances (TBARS, an indicator of lipid peroxidation). Angiography was carried out before and 15 min after angioplasty, and at follow-up (4 months after angioplasty), and evaluated using a quantitative approach. There were 23 patients with restenosis (group R) and 64 patients without restenosis (group N) after coronary balloon angioplasty. The plasma TEARS level (mean +/- SEM) of 4.3 +/- 0.1 mu mol/L in group R was significantly higher than that of 3.2 +/- 0.1 mu mol/L in group N (p < 0.01). There were no significant differences in other parameters, including plasma lipid levels, between the 2 groups. The plasma level of TEARS positively correlated with lumen loss of the coronary artery at the time of follow-up angiography (r = 0.57, p < 0.01). Our results suggest that oxidative stress contributes to restenosis and indicate that an elevated plasma level of TEARS may be a reliable predictor of restenosis.
引用
收藏
页码:495 / 499
页数:5
相关论文
共 38 条
[1]
Regional remodeling of atherosclerotic arteries: A major determinant of clinical manifestations of disease [J].
Birnbaum, Y ;
Fishbein, MC ;
Luo, H ;
Nishioka, T ;
Siegel, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (05) :1149-1164
[2]
Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty [J].
Boullier, A ;
Walters-Laporte, E ;
Hamon, M ;
Tailleux, A ;
Amant, C ;
Amouyel, P ;
Fruchart, JC ;
Bertrand, M ;
Duriez, P .
CLINICA CHIMICA ACTA, 2000, 299 (1-2) :129-140
[3]
Beyond cholesterol reduction in coronary heart disease: Is vitamin E the answer? [J].
Cockcroft, J ;
Chowienczyk, P .
HEART, 1996, 76 (04) :293-294
[4]
Effects of probucol on vascular remodeling after coronary angioplasty [J].
Côté, G ;
Tardif, JC ;
Lespérance, J ;
Lambert, J ;
Bourassa, M ;
Bonan, R ;
Gosselin, G ;
Joyal, M ;
Tanguay, JF ;
Nattel, S ;
Gallo, R ;
Crépeau, J .
CIRCULATION, 1999, 99 (01) :30-35
[5]
DEMAIO SJ, 1992, J AM COLL NUTR, V11, P68
[6]
AUTOANTIBODIES TO OXIDIZED LOW-DENSITY LIPOPROTEINS IN RESTENOSIS FOLLOWING CORONARY ANGIOPLASTY [J].
EBER, B ;
SCHUMACHER, M ;
TATZBER, F ;
KAUFMANN, P ;
LUHA, O ;
ESTERBAUER, H ;
KLEIN, W .
CARDIOLOGY, 1994, 84 (4-5) :310-315
[7]
A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].
FISCHMAN, DL ;
LEON, MB ;
BAIM, DS ;
SCHATZ, RA ;
SAVAGE, MP ;
PENN, I ;
DETRE, K ;
VELTRI, L ;
RICCI, D ;
NOBUYOSHI, M ;
CLEMAN, M ;
HEUSER, R ;
ALMOND, D ;
TEIRSTEIN, PS ;
FISH, RD ;
COLOMBO, A ;
BRINKER, J ;
MOSES, J ;
SHAKNOVICH, A ;
HIRSHFELD, J ;
BAILEY, S ;
ELLIS, S ;
RAKE, R ;
GOLDBERG, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501
[8]
Long-term prognosis in achieving a 'stent-like' result from balloon angioplasty - 8 years' clinical outcome [J].
Fukuzawa, S ;
Ozawa, S ;
Inagaki, M ;
Sugioka, J ;
Daimon, M ;
Kushida, S .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1999, 63 (01) :33-36
[9]
Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty [J].
George, J ;
Harats, D ;
Bakshi, E ;
Adler, Y ;
Levy, Y ;
Gilburd, B ;
Shoenfeld, Y .
IMMUNOLOGY LETTERS, 1999, 68 (2-3) :263-266
[10]
CYPRIDINA-LUCIFERIN ANALOG REDUCES THE INCIDENCE OF ISCHEMIA REPERFUSION-INDUCED VENTRICULAR-FIBRILLATION [J].
KANASHIRO, M ;
MATSUBARA, T ;
GOTO, T ;
SAKAMOTO, N .
JAPANESE JOURNAL OF PHARMACOLOGY, 1993, 63 (01) :47-52